A 70-marker blood panel designed for people taking GLP-1 weight-loss medication, covering nutritional health, liver and kidney function, and personal health measurements.
60 biomarkers as listed by Randox Health, of 70 in total.
This panel spans thyroid function and antibodies, cholesterol, diabetes and blood sugar markers, full blood count, iron status, kidney and liver function, nutritional markers, pancreatic markers, and personal health measurements including blood pressure, waist and hip circumference, height, oxygen saturation and body composition. The provider positions it specifically for people starting or already taking GLP-1 medications such as Ozempic, Mounjaro or Wegovy, to establish a baseline and monitor nutritional health, liver and kidney function, and pancreatic markers during treatment, since these medications can reduce appetite and food intake.
There is no comparison group set up for this test, so we cannot benchmark its £197 price or 70-marker depth against named rivals in our data.
The scores reflect a very broad, well-documented panel with an untested price point. Clinical depth is the maximum score, with 70 biomarkers placing it at the top of the metabolism tests we track. Collection convenience is limited by the clinic visit, even though results return within 2 days. Value for money is only middling, since there is nothing yet to compare the £197 price against. Results and follow-up scores lower since results are not reviewed by a doctor as standard.
This suits people already taking or starting a GLP-1 weight-loss medication who want a broad baseline and periodic monitoring, since the provider suggests retesting every 3 to 6 months during treatment. It is not aimed at general weight management without medication. If only specific markers matter to you, such as vitamins or thyroid function alone, Randox's smaller standalone panels are cheaper.
You attend a Randox Health clinic for a venous blood draw. The lab analyses 70 biomarkers alongside recorded personal health measurements, with results available within 48 hours of the sample arriving, though they are not reviewed by a doctor as standard.
This test covers 70 biomarkers plus personal health measurements such as blood pressure and body composition, positioned by the provider for people taking GLP-1 weight-loss medications. At £197 there is no comparable test in our data yet to judge value against, and results are not reviewed by a doctor as standard.
The listing publishes a detailed description, the full biomarker list, a stated turnaround, clear collection options, the sample type; it does not state what the report looks like.
70 biomarkers, placing it in the 100th percentile of metabolism tests we track.
Requires a venous draw at a clinic; results in around 2 days, well ahead of the metabolism norm of 5.
Results are not doctor-reviewed and no consultation is included; the provider does not describe the report format.
Trustpilot 4.6 from 29,705 reviews; accredited lab (UKAS ISO 15189 (Randox Clinical Laboratory Services, lab 9329)); CQC registered.
£197.00; no comparable tests to benchmark against yet.
Calculated 13 September 2026 from the facts we hold about this test and provider, using our published scoring formula. Scores are not hand-edited.
Mid-depth metabolic panel priced well below peers
Measures 19 markers of blood sugar, cholesterol, liver, kidney and inflammation to give a broad view of metabolic health.
Below-median price for a single-marker uric acid test
A single-marker blood test measuring uric acid, used to help monitor gout risk and related joint, kidney and metabolic health.
21-marker Dulaglutide monitoring panel
A 21-marker blood panel that checks kidney function, liver function, cholesterol, blood sugar (HbA1c) and pancreas health, aimed at people taking the GLP-1 medication Dulaglutide (Trulicity). Suits ongoing monitoring rather than a first general health check.
21-marker monitoring panel for Saxenda users
A 21-marker blood panel covering kidney, liver, lipid and blood sugar markers plus lipase, aimed at people taking daily injectable liraglutide (Saxenda) who want to monitor how their body is responding over time.
